Skip to content

Incyte INCY EV / sales

EV / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
3.3×-0.1×
Pfizer logo
PfizerPFE
3.5×+0.3×
Gilead Sciences logo
Gilead SciencesGILD
6.3×+0.9×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Amgen logo
AmgenAMGN
6.6×+0.1×
Biogen logo
BiogenBIIB
+0.8×

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.8%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$19.78B+59.9%
Enterprise value$16.35B+55.9%
P/E13.8×-568×
P/S3.7×+0.9×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0.0×
Current ratio3.7×+1.6×

Where this comes from

Calculated from Incyte’s reported figures.

Based on the most recent quarter.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's EV / sales?
Incyte (INCY) reported EV / sales of 2.9× in Q1 2026.
How has Incyte's EV / sales changed year-over-year?
Incyte's EV / sales increased by 28.4% year-over-year, from 2.2× to 2.9×.
What is the long-term trend for Incyte's EV / sales?
Over 4 years (2021 to 2025), Incyte's EV / sales has grown at a -15.8% compound annual growth rate (CAGR), from 21.5× to 10.8×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.